Berenberg Bank Trims Synthomer (LON:SYNT) Target Price to GBX 275 | MarketBeat

2022-08-08 12:14:56 By : Mr. Gawain Tang

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Synthomer (LON:SYNT - Get Rating) had its target price dropped by equities researchers at Berenberg Bank from GBX 350 ($4.29) to GBX 275 ($3.37) in a research report issued on Thursday, MarketBeat Ratings reports. The firm presently has a "hold" rating on the stock. Berenberg Bank's price objective would indicate a potential upside of 43.38% from the company's previous close.

Several other analysts also recently issued reports on SYNT. JPMorgan Chase & Co. cut their price objective on Synthomer from GBX 430 ($5.27) to GBX 350 ($4.29) and set a "neutral" rating on the stock in a report on Wednesday. Barclays reissued an "equal weight" rating and issued a GBX 323 ($3.96) price target on shares of Synthomer in a research note on Wednesday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of GBX 484.13 ($5.93).Synthomer Stock Performance

SYNT stock opened at GBX 191.80 ($2.35) on Thursday. The stock has a market capitalization of £896.35 million and a price-to-earnings ratio of 396.67. The company has a debt-to-equity ratio of 64.18, a quick ratio of 1.43 and a current ratio of 1.91. Synthomer has a 1 year low of GBX 189.40 ($2.32) and a 1 year high of GBX 570.50 ($6.99). The stock's fifty day moving average is GBX 252.48 and its two-hundred day moving average is GBX 289.86. Insider Activity at Synthomer

In related news, insider Roberto Gualdoni bought 20,000 shares of the business's stock in a transaction on Tuesday, August 2nd. The shares were purchased at an average price of GBX 214 ($2.62) per share, with a total value of £42,800 ($52,444.55). About Synthomer (Get Rating)

Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic polymers, acrylic dispersions, saturants, release coatings, and other adhesives; water-based carboxylated styrene butadiene rubber, redispersible powder, flooring adhesive, and additives for construction applications; and impregnation binders, styrene butadiene copolymers, dispersions, polymer binders, and butadiene-based binders for textiles applications.Featured StoriesWarner Brothers Discovery is a Powerhouse Entertainment Play3 Pharma Stocks' Post-Earnings Price Moves Devon Energy Looks Attractive if You Look Past the Headlines 3 Low Priced Stocks With Good Growth ProspectsThe Institutions Are Buying Under Armor Again

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Today, Kate’s guest is Rhys Williams, chief investment officer for the Opportunistic All Cap Equity, a long-short strategy at Spouting Rock Asset Management.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.